EFSA has been accused of overlooking low-dosage effects of chemicals
The recent EFSA Scientific Committee Opinion draft on the biological plausibility of non-monotonic dose responses (NMDR) and their impact on risk assessment has been characterized as “inaccurate” by the End [...]